Navigation Links
Global Biopharmaceuticals Market 2011-2015

NEW YORK, July 23, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Biopharmaceuticals Market 2011-2015

TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biopharmaceuticals landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Pfizer Inc., Abbott Laboratories Inc., Sanofi S.A., AstraZeneca plc, and Johnson and Johnson Services Inc. Other vendors in the market are GlaxoSmithKline plc, Merck Sereno S.A., UCB S.A., and Boehringer Ingelheim GmbH.

Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.01. Executive Summary 02. Introduction 03. Market Coverage Market Overview Key Products 04. Market Landscape Market Size Market Segmentation 04.1 Global Monoclonal Antibodies Market 04.2 Global Growth Factors Market 04.3 Global Insulin Market 04.4 Global Growth Hormones Market Five Forces Analysis 05. Geographical Segmentation 06. Key Leading Countries USA Japan UK Germany 07. Rate of Incidence and Prevalence Cancer Musculoskeletal Diseases Diabetes Influenza Hepatitis C 08. Vendor Landscape 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact Drivers and their Impact: End-users Drivers and their Impact: Geography Key 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1 Pfizer Inc. Business Overview SWOT Analysis 15.2 Abbott Laboratories Inc. Business Overview SWOT Analysis 15.3 Sanofi S.A. Business Overview SWOT Analysis 15.4 AstraZeneca plc Business Overview SWOT Analysis 15.5 Johnson and Johnson Services Inc. Business Overview SWOT Analysis 16. Other Reports in this Series

List of Exhibits:

Exhibit 1: Biologic Segmentation of the Global Biopharmaceuticals Market

Exhibit 2: Global Biopharmaceuticals Market 2011-2015 (US$ billion)

Exhibit 3: Global Biopharmaceuticals Market Segmentation by Biologic Components 2011

Exhibit 4: Global Biopharmaceuticals Market 2011-2015 (percent)

Exhibit 5: Global Biopharmaceuticals Market 2011-2015 (in US$ billion)

Exhibit 6: Global Monoclonal Antibodies Market 2011-2015 (US$ billion)

Exhibit 7: Global Growth Factors Market 2011-2015 (US$ billion)

Exhibit 8: Biologic Segmentation of the Global Growth Factors Market

Exhibit 9: Global Growth Factors Market Segmentation by Biologic Components 2011

Exhibit 10: Global Growth Factors Market 2011-2015 (percent)

Exhibit 11: Global Growth Factors Market 2011-2015 (in US$ billion)

Exhibit 12: Global Insulin Market 2011-2015 (US$ billion)

Exhibit 13: Global Growth Hormones Market 2011-2015 (US$ billion)

Exhibit 14: Global Biopharmaceuticals Market by Geographical Segmentation 2011

Exhibit 15: Hepatitis C Infection by Source in 2011

Exhibit 16: Global Biopharmaceuticals Market by Vendor Segmentation 2011

To order this report:Biopharmaceutical Industry: Global Biopharmaceuticals Market 2011-2015

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626


SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... in scientifically backed, age-defying products, is featured as the cover story and ... success and unrivaled opportunities that Nerium provides. Success from Home magazine routinely ...
(Date:12/1/2015)... 1, 2015 Dr. Harry Lander , President of Regen, ... Chief Science Officer and recruits five distinguished ... , President of Regen, expands his role to include ... recruits five distinguished scientists to join advisory team ... his role to include serving as Chief ...
(Date:12/1/2015)... DUBLIN , December 1, 2015 /PRNewswire/ ... the addition of the  "2016 U.K. Virology ... Segment Forecasts for 100 Tests, Supplier Shares ... Opportunities"  report to their offering.  --> ... of the  "2016 U.K. Virology and Bacteriology ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells Group ... in the Santiago Marriott. The Global Stem Cells Group GMP facility is equipped ... of qualified medical researchers and practitioners, experienced in administering stem cell protocols using ...
Breaking Biology Technology:
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
Breaking Biology News(10 mins):